Talaris Therapeutics   Report issue

For profit Phase 2 Phase 3
Founded: Louisville KY United States (2002)

Organization Overview

First Clinical Trial
2008
NCT00497926
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Talaris Therapeutics | Talaris Therapeutics Inc. | Tourmaline Bio, Inc.

Active Ingredients

Drugs in Phase 3 Trials (1)

fcr001 (2 trials)

Drugs in Phase 2 Trials (2)

hemopoietic stem cell (2 trials)

tour006 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Renal Insufficiency (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 3